Amyris, Inc. was a big mover last session, as its shares rose over 7% on the day. The move came on the back of the company’s announcement of a new collaboration in the field of cosmetic active ingredients with Givaudan. This led to far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down 35.1% in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Amyris currently has a Zacks Rank #3 (Hold) while the Earnings ESP is 0.00%.
A better-ranked stock in the biofuels industry is Enviva Partners, LP (EVA - Free Report) which sports a Zacks Rank #1 (Strong Buy).
Is AMRS going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Amyris, Inc. was a big mover last session, as its shares rose over 7% on the day. The move came on the back of the company’s announcement of a new collaboration in the field of cosmetic active ingredients with Givaudan. This led to far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down 35.1% in the past one-month time frame.
None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Amyris currently has a Zacks Rank #3 (Hold) while the Earnings ESP is 0.00%.
A better-ranked stock in the biofuels industry is Enviva Partners, LP (EVA - Free Report) which sports a Zacks Rank #1 (Strong Buy).
Is AMRS going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on EVA - FREE